Palbociclib,Fulvestrant
Pfizer
['breast', ' fulv', 'palbo']
 #asco23 pada-1 trial. early switch to fulvestrant in patients with metastatic breast ca on a.i. +palbo based on esr1 mutation found via ctdna. result: improvement in 2nd pfs of 15.4 months with early fulvestant.
Breast med oncology, chief hem/onc @NYPBrooklyn, prof clinical med @WeillCornell, ethics/spirituality in medicine; long time NY #Jets sufferer; tweets my own